Canada South Africa covid-19 testing vaccine Canada South Africa

Novavax says it’s developing COVID-19 vaccine to target new Omicron variant

Reading now: 898
globalnews.ca

COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks.The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system.

The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.“The initial work will take a few weeks,” a company spokesperson said.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA